DrugPatentWatch Database Preview
Corepharma Company Profile
» See Plans and Pricing
What is the competitive landscape for COREPHARMA, and what generic and branded alternatives to COREPHARMA drugs are available?
COREPHARMA has seven approved drugs.
There is one tentative approval on COREPHARMA drugs.
Summary for Corepharma
| US Patents: | 0 |
| Tradenames: | 7 |
| Ingredients: | 7 |
| NDAs: | 7 |
Drugs and US Patents for Corepharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corepharma | EPLERENONE | eplerenone | TABLET;ORAL | 078482-002 | Jul 30, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Corepharma | LISINOPRIL | lisinopril | TABLET;ORAL | 076102-006 | Sep 30, 2002 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Corepharma | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 200263-002 | Jun 19, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
